Logo

JP Morgan

JPM Healthcare Conference Day 2: Thermo Fisher, BD, SomaLogic, Myriad, Oxford Nanopore, More

Highlights of the second day included Myriad Genetics' new oncology testing service and more details on SomaLogic's partnership with Illumina.

JP Morgan Initiates Coverage of Oxford Nanopore Technologies With Overweight Rating

Oxford Nanopore is a "differentiated player, operating in an attractive segment, with a very strong long-term top-line growth outlook," according to a JP Morgan analyst.

PerkinElmer Reaches Deal for $1.5B Credit Facility

The agreement is for a new credit facility, which replaces one from 2019 that provided for a $1 billion unsecured revolving credit facility.

JP Morgan, Cowen Initiate Coverage of Sophia Genetics With Overweight, Outperform Ratings

Both investment banks are bullish on the genomic data analysis firm, which went public on the Nasdaq a month ago, raising $234 million in gross proceeds.

PerkinElmer Enters $500M Credit Facility

The proceeds will be used to pay, in part, PerkinElmer's $5.25B acquisition of BioLegend, announced last month.

Jun 21, 2021

JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems

May 24, 2021

Singular Genomics Ups IPO Target to $187M

May 12, 2021

Sequencing Startup Singular Genomics Files for $100M IPO

Feb 18, 2021

Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO

Jan 14, 2021

JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Jan 13, 2021

JP Morgan Healthcare Conference 2021, Day 2: Qiagen, Invitae, Agilent, Sema4, More

Jan 13, 2021

At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing

Jan 12, 2021

Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition
Premium

Jan 12, 2021

JP Morgan Healthcare Conference 2021, Day 1: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher

Jan 11, 2021

PerkinElmer CEO Talks COVID-19, Long-Term Outlook at JP Morgan

Dec 3, 2020

Twist Bioscience Prices Upsized $300M Public Offering

Dec 2, 2020

Twist Bioscience Proposes $250M Public Offering

Nov 3, 2020

Pacific Biosciences Gears Up For Commercial, R&D Push With Eye Toward Collaborations
Premium

Oct 14, 2020

JP Morgan Rates Invitae Neutral

Oct 8, 2020

NanoString Technologies Prices $200M Public Offering

Oct 7, 2020

NanoString Technologies Q3 Preliminary Product, Service Revenues Grow 14 Percent

Oct 2, 2020

Pacific Biosciences Upgraded to Overweight by JP Morgan

Sep 21, 2020

Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider
Premium

Sep 21, 2020

JP Morgan Downgrades Illumina to Neutral on Grail Deal

Sep 11, 2020

10x Genomics Prices Upsized $440M Public Offering

Breaking News
The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.